In a letter today, AHA again urged the Center for Medicare & Medicaid Innovation to delay the start date for its new radiation oncology alternative payment model until Jan. 1, 2022. The complex model, which will be mandatory in certain areas of the country and for which many details are still forthcoming, “would be difficult to implement in three months in the best of circumstances; it will be nearly impossible to implement in three months during a public health emergency,” AHA wrote.

AHA also urged CMMI to reconsider sudden changes to the Bundled Payments for Care Improvement Advanced model effective Jan. 1, especially the move to clinical episode service line groups. “Requiring model participants to take on risk for large, diverse bundles of episodes — instead of allowing them to choose individual episodes as is current policy — will require more financial risk than many participants can currently bear,” AHA wrote. It urged the agency at least to delay the changes for a year so participants can model their impact before having to make participation decisions.  

Related News Articles

Headline
The Supreme Court April 29 ruled 7-2 in favor of the Department of Health and Human Services in a case that challenged how HHS applied Congress’ formula for…
Headline
The House Energy and Commerce Committee held a markup April 29 where it advanced the AHA-supported SUPPORT Act (H.R. 2483). The legislation would reauthorize…
Headline
Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy, M.D., R-La., today released a report detailing findings from an investigation…
Headline
The AHA April 18 filed friend-of-the-court briefs in three cases in support of Louisiana's 340B contract pharmacy law that prohibits drug companies from…
Perspective
Public
Just 16 days from now, more than 1,000 hospital and health system leaders from across the country will arrive in Washington, D.C., for the 2025 AHA Annual…
Headline
A Minnesota state court April 15 dismissed a lawsuit filed by PhRMA challenging the state’s law protecting 340B pricing for contract pharmacy arrangements. The…